The Psychosocial Characteristics and Somatosensory Function of Children and Adolescents Who Meet the Criteria for Chronic Nociplastic Pain

Purpose Nociplastic pain distinguishes individuals with pain and hypersensitivity in body regions with apparently normal tissues, without any signs of neuropathy, but with contribution of central and/or peripheral sensitization. There is a lack of literature describing nociplastic pain in the pediatric population. The objective of this study was to investigate the differences between pediatric patients with nociplastic pain compared with patients with non-nociplastic pain. Patients and Methods This study included 414 pediatric patients followed at an interdisciplinary centre for complex pain. All patients underwent an exhaustive pain assessment consisting of face-to-face interviews, validated self-report questionnaires and quantitative sensory testing. Recently established criteria for chronic nociplastic pain, and quantitative sensory testing was used to describe and stratify our cohort. Results One hundred and sixty-five patients (40%) were stratified as having possible nociplastic pain and two hundred and forty-nine (60%) patients, as non-nociplastic pain. Patients with nociplastic pain displayed pain hypersensitivity in the region of pain, more symptoms of panic and social phobia, and worse sleep quality than patients with non-nociplastic pain. The proportion of patients achieving a meaningful clinical outcome after completion of their treatment (medications, physiotherapy, psychology, nursing, social worker, and/or interventional procedures) was lower in patients with nociplastic pain (62%) than those without nociplastic pain (86%). Conclusion Our results suggest that patients who meet the criteria for nociplastic pain can be identified in a population of children and adolescents being treated in a center for complex pain. Combining screening with validated questionnaires and quantitative sensory testing facilitates the phenotyping and graded severity of patients with nociplastic pain in daily clinical practice.

[1]  Chelsea M. Kaplan,et al.  Pain Widespreadedness, and Not Primary Pain Location, is Associated With Comorbid Symptoms in Children With Chronic Pain , 2022, The Clinical journal of pain.

[2]  P. Ingelmo,et al.  Mechanism-Based Pharmacological Treatment for Chronic Non-cancer Pain in Adolescents: Current Approaches and Future Directions , 2022, Pediatric Drugs.

[3]  M. Curatolo,et al.  Association between the Use of Quantitative Sensory Testing and Conditioned Pain Modulation and the Prescription of Medication and Interventional Procedures in Children with Chronic Pain Conditions , 2022, Children.

[4]  G. Lus,et al.  Nociplastic Pain in Multiple Sclerosis Spasticity: Dermatomal Evaluation, Treatment with Intradermal Saline Injection and Outcomes Assessed by 3D Gait Analysis: Review and a Case Report , 2022, International journal of environmental research and public health.

[5]  J. Ouellet,et al.  Phenotyping Chronic Musculoskeletal Pain in Male and Female Adolescents: Psychosocial Profiles, Somatosensory Profiles and Pain Modulatory Profiles , 2022, Journal of pain research.

[6]  S. Ohtori,et al.  Mechanism of Chronic Pain of Symptomatic Hip Osteoarthritis by Association of its Distribution, Nociceptive, Neuropathic, Nociplastic, or Mixed-pain Screening, and the Prevalence of Lumbar Spinal Stenosis , 2021, The Clinical journal of pain.

[7]  David A. Williams,et al.  Neurobiological antecedents of multisite pain in children. , 2021, Pain.

[8]  Steven P. Cohen,et al.  Nociplastic pain: towards an understanding of prevalent pain conditions , 2021, The Lancet.

[9]  Richard E. Harris,et al.  Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system. , 2021, Pain.

[10]  C. Eccleston,et al.  Efficacy and safety of pharmacological, physical, and psychological interventions for the management of chronic pain in children: a WHO systematic review and meta-analysis. , 2021, Pain.

[11]  Y. Uziel,et al.  Juvenile primary Fibromyalgia Syndrome: epidemiology, etiology, pathogenesis, clinical manifestations and diagnosis , 2021, Pediatric Rheumatology.

[12]  G. Crombez,et al.  Core outcome set for pediatric chronic pain clinical trials: results from a Delphi poll and consensus meeting , 2021, Pain.

[13]  Ishtiaq Mawla,et al.  Altered network architecture of functional brain communities in chronic nociplastic pain , 2020, NeuroImage.

[14]  Jason A Zafereo,et al.  Quantitative Sensory Testing Discriminates Central Sensitization Inventory Scores in Participants with Chronic Musculoskeletal Pain: An Exploratory Study , 2020, Pain practice : the official journal of World Institute of Pain.

[15]  S. Walker,et al.  Phenotyping peripheral neuropathic pain in male and female adolescents: pain descriptors, somatosensory profiles, conditioned pain modulation and child-parent reported disability. , 2020, Pain.

[16]  G. Crombez,et al.  Delivering transformative action in paediatric pain: a Lancet Child & Adolescent Health Commission. , 2020, The Lancet. Child & adolescent health.

[17]  M. Meeus,et al.  Prescription of exercises for the treatment of chronic pain along the continuum of nociplastic pain: A systematic review with meta‐analysis , 2020, European journal of pain.

[18]  C. Eccleston,et al.  Pharmacological interventions for chronic pain in children: an overview of systematic reviews. , 2019, Pain.

[19]  R. Malik,et al.  Faculty Opinions recommendation of Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendations. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[20]  G. Echevarría,et al.  Interventional procedures in children and adolescents with chronic non‐cancer pain as part of a multidisciplinary pain treatment program , 2018, Paediatric anaesthesia.

[21]  P. Ingelmo,et al.  Chronic non-cancer pain in children: we have a problem, but also solutions. , 2018, Minerva anestesiologica.

[22]  P. Jackson,et al.  Multicenter assessment of quantitative sensory testing (QST) for the detection of neuropathic-like pain responses using the topical capsaicin model , 2018, Canadian journal of pain = Revue canadienne de la douleur.

[23]  Andreas C. Themistocleous,et al.  Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendations , 2017, Pain.

[24]  R. Treede,et al.  Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles , 2016, Pain.

[25]  W. Rief,et al.  Do we need a third mechanistic descriptor for chronic pain states? , 2016, Pain.

[26]  Craig A. Smith,et al.  Functional abdominal pain patient subtypes in childhood predict functional gastrointestinal disorders with chronic pain and psychiatric comorbidities in adolescence and adulthood , 2012, PAIN®.

[27]  P. McGrath,et al.  The epidemiology of chronic pain in children and adolescents revisited: A systematic review , 2011, PAIN.

[28]  R. Levy.  Exploring the Intergenerational Transmission of Illness Behavior: From Observations to Experimental Intervention , 2011, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[29]  H. Flor,et al.  Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes , 2010, PAIN.

[30]  M. Blankenburg,et al.  Reference values for quantitative sensory testing in children and adolescents: Developmental and gender differences of somatosensory perception , 2010, PAIN®.

[31]  Y. Tousignant-Laflamme,et al.  An experimental model to measure excitatory and inhibitory pain mechanisms in humans , 2008, Brain Research.

[32]  Steven Weisman,et al.  Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations. , 2008, The journal of pain : official journal of the American Pain Society.

[33]  David Cella,et al.  Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. , 2008, The journal of pain : official journal of the American Pain Society.

[34]  Arthur R. Williams,et al.  Validity of the revised Impact on Family (IOF) scale. , 2006, The Journal of pediatrics.

[35]  G. Crombez,et al.  Parental catastrophizing about their child’s pain. The parent version of the Pain Catastrophizing Scale (PCS-P): A preliminary validation , 2006, PAIN.

[36]  Bernard Laurent,et al.  Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) , 2005, Pain.

[37]  G. Crombez,et al.  The child version of the pain catastrophizing scale (PCS-C): a preliminary validation , 2003, Pain.

[38]  J. Farrar,et al.  Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale , 2001, PAIN.

[39]  B. Chorpita,et al.  Assessment of symptoms of DSM-IV anxiety and depression in children: a revised child anxiety and depression scale. , 2000, Behaviour research and therapy.

[40]  L. Walker,et al.  The functional disability inventory: measuring a neglected dimension of child health status. , 1991, Journal of pediatric psychology.

[41]  Daniel J Buysse,et al.  The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research , 1989, Psychiatry Research.

[42]  C. Riessman,et al.  The development of an impact-on-family scale: preliminary findings. , 1980, Medical care.